Logo-jnp
J Nephropathol. 2013;2(1): 20-27. doi: 10.5812/nephropathol.9093
PMID: 24475422        PMCID: PMC3886179

Review Article

Diabetic nephropathy and antioxidants

Majid Tavafi *

Cited by CrossRef: 97

1- Zhang T, Liu C, Ma S, Gao Y, Wang R. Protective Effect and Mechanism of Action of Rosmarinic Acid on Radiation-Induced Parotid Gland Injury in Rats. Dose-Response. 2020;18(1):155932582090778 [Crossref]
2- Tian E, Wang F, Zhao L, Sun Y, Yang J. The pathogenic role of intestinal flora metabolites in diabetic nephropathy. Front Physiol. 2023;14 [Crossref]
3- Ma Y, Bao M, Peng Y, Gao J, Bao J. Eco-friendly Nanoparticles Synthesized from Salvia sclarea Ethanol Extract Protect against STZ-induced Diabetic Nephropathy in Rats via Antioxidant, Anti-inflammatory, and Apoptosis Mechanisms. J Oleo Sci. 2024;73(8):1057 [Crossref]
4- Samsu N, Bellini M. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed Research International. 2021;2021:1 [Crossref]
5- Zhao L, Zhang H, Li N, Chen J, Xu H, Wang Y, Liang Q. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. Journal of Ethnopharmacology. 2023;309:116306 [Crossref]
6- Ghalishourani S, Farzollahpour F, Shirinbakhshmasoleh M, Kolahdouz S, Ghaedi E, Behrouzian M, Haghighian H, Campbell M, Asbaghi O, Moodi V. Effects of grape products on inflammation and oxidative stress: A systematic review and meta‐analysis of randomized controlled trials. Phytotherapy Research. 2021;35(9):4898 [Crossref]
7- Deng J, Liu Y, Liu Y, Li W, Nie X. The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy. JIR. 2021;Volume 14:5273 [Crossref]
8- Zafar H, Malik I, Bushra H, Alam K, Shakeel M, Ahmed I, Gul H, Elsadek M, Al-Numair K, Ahmad N, Yasin M. The relationship between ACE gene insertion/deletion polymorphism and diabetes retinopathy patients with diabetes type 1. Int J Diabetes Dev Ctries. 2024; [Crossref]
9- Nazarian-Samani Z, Sewell R, Lorigooini Z, Rafieian-Kopaei M. Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review. Curr Diab Rep. 2018;18(10) [Crossref]
10- Hou Y, Shi Y, Han B, Liu X, Qiao X, Qi Y, Wang L. The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic nephropathy. 2018;33(11):1908 [Crossref]
11- Du Y, Wang L, Qian J, Zhang K, Chai K. Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats. Chin J Integr Med. 2016;22(12):910 [Crossref]
12- Hou Y, Li S, Wu M, Wei J, Ren Y, Du C, Wu H, Han C, Duan H, Shi Y. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy. American Journal of Physiology-Renal Physiology. 2016;310(6):F547 [Crossref]
13- Saeedi Saravi S, Hasanvand A, Shahkarami K, Dehpour A. The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice. Pharmaceutical Biology. 2016;54(12):2830 [Crossref]
14- Jaiswal A, Chandra Semwal B, Singh S. A Compressive Review on Novel Molecular Target of Diabetic Nephropathy. RJPT. 2022;:1398 [Crossref]
15- Rahbardar M, Amin B, Mehri S, Mirnajafi-Zadeh S, Hosseinzadeh H. Rosmarinic acid attenuates development and existing pain in a rat model of neuropathic pain: An evidence of anti-oxidative and anti-inflammatory effects. Phytomedicine. 2018;40:59 [Crossref]
16- Charlton A, Garzarella J, Jandeleit-Dahm K, Jha J. Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes. Biology. 2020;10(1):18 [Crossref]
17- Thomas A, Bankar N, Nagore D, Kothapalli L, Chitlange S. Herbal Oils for Treatment of Chronic and Diabetic Wounds: A Systematic Review. CDR. 2022;18(2) [Crossref]
18- Singh H, Singh R, Singh A, Singh H, Singh G, Kaur S, Singh B. Role of oxidative stress in diabetes-induced complications and their management with antioxidants. Archives of Physiology and Biochemistry. 2023;:1 [Crossref]
19- Mohd Nasir S, Ismail A, Tuan Ismail T, Wan Abdul Rahman W, Wan Ahmad W, Tengku Din T, Sirajudeen K. Hepatic and renal effects of oral stingless bee honey in a streptozotocin-induced diabetic rat model. World J Exp Med. 2024;14(1) [Crossref]
20- Nasri R. Renoprotective effects of metformin. DARU J Pharm Sci. 2013;21(1) [Crossref]
21- Mohamad M, El-Sherbeny E, Bekhet M. The Effect of Vitamin D Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus. Journal of the American College of Nutrition. 2016;35(5):399 [Crossref]
22- Mehanna O, El Askary A, Al-Shehri S, El-Esawy B. Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats. Archives of Physiology and Biochemistry. 2018;124(5):424 [Crossref]
23- Liu X, Wang X, Ma H, Zhang W. Mechanisms underlying acupuncture therapy in chronic kidney disease: A narrative overview of preclinical studies and clinical trials. Front Nephrol. 2022;2 [Crossref]
24- Baig N, Sultan R, Qureshi S. Antioxidant and anti-inflammatory activities of Centratherum anthelminticum (L.) Kuntze seed oil in diabetic nephropathy via modulation of Nrf-2/HO-1 and NF-κB pathway. BMC Complement Med Ther. 2022;22(1) [Crossref]
25- De La Cruz J, Osuna-Esteban L, Rodríguez-Pérez M, Ortega-Hombrados L, Sánchez-Tévar A, Martín-Aurioles E, Fernández-Prior M, Pérez-Burillo S, Espejo-Calvo J, González-Correa J. Effect of a Triterpenoid-Rich Olive Oil on Chronic Kidney Disease in an Experimental Model of Diabetes Mellitus. Nutrients. 2024;16(16):2794 [Crossref]
26- Huang H, Luo Y, Wang Q, Zhang Y, Li Z, He R, Chen X, Dong Z. Vaccinium as Potential Therapy for Diabetes and Microvascular Complications. Nutrients. 2023;15(9):2031 [Crossref]
27- Laustsen C, Nielsen P, Nørlinger T, Qi H, Pedersen U, Bertelsen L, Østergaard J, Flyvbjerg A, Ardenkjær-Larsen J, Palm F, Stødkilde-Jørgensen H. Antioxidant treatment attenuates lactate production in diabetic nephropathy. American Journal of Physiology-Renal Physiology. 2017;312(1):F192 [Crossref]
28- Widyawati T, Syarifah S, Rita Anggraini D, Sari Wahyuni A, Indah Sari M, Feriyawati L. Lawsonia inermis linnaeus leaf ethyl acetate extract evaluation on the kidneys of rats. J Phys: Conf Ser. 2019;1317(1):012091 [Crossref]
29- Antony P, Vijayan R, Zheng J. Identification of Novel Aldose Reductase Inhibitors from Spices: A Molecular Docking and Simulation Study. PLoS ONE. 2015;10(9):e0138186 [Crossref]
30- Feng G, Gao J, Zhang P, Huang J, Huang L, Cheng L, Pu C. Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus. Acta Diabetol. 2017;54(11):1047 [Crossref]
31- Almogbel E, Rasheed N. Elevated Levels of Protein Carbonylation in Patients With Diabetic Nephropathy: Therapeutic and Diagnostic Prospects. The American Journal of the Medical Sciences. 2019;358(1):26 [Crossref]
32- Kassab B, Hussein H, Mahmoud O, Abdel-Alrahman G. Effects of insulin and metformin on fetal kidney development of streptozotocin-induced gestational diabetic albino rats. Anat Cell Biol. 2019;52(2):161 [Crossref]
33- Sun Y, Jin D, Zhang Z, Zhang Y, Zhang Y, Kang X, Jiang L, Tong X, Lian F. Effects of antioxidants on diabetic kidney diseases: mechanistic interpretations and clinical assessment. Chin Med. 2023;18(1) [Crossref]
34- Wu C, Hung C, Shin Y, Wang C, Huang H. Myrciaria cauliflora extracts attenuate diabetic nephropathy involving the Ras signaling pathway in streptozotocin/nicotinamide mice on a high fat diet. Journal of Food and Drug Analysis. 2016;24(1):136 [Crossref]
35- Yaribeygi H, Hemmati M, Nasimi F, Maleki M, Jamialahmadi T, Reiner I, Reiner Ž, Sahebkar A. Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats. JCM. 2023;12(11):3815 [Crossref]
36- Azarova I, Klyosova E, Polonikov A. Single Nucleotide Polymorphisms of the RAC1 Gene as Novel Susceptibility Markers for Neuropathy and Microvascular Complications in Type 2 Diabetes. Biomedicines. 2023;11(3):981 [Crossref]
37- Li Y, Li X, He K, Li B, Liu K, Qi J, Wang H, Wang Y, Luo W. C‐peptide prevents NF‐κB from recruiting p300 and binding to the inos promoter in diabetic nephropathy . FASEB j. 2018;32(4):2269 [Crossref]
38- Yaribeygi H, Mohammadi M. Evaluation of PPAR-α Agonist effect on Kidney Performance Through Increment of Nitric Oxide During Hyperglycemia-Induced Nephropathy in Rat. Razavi Int J Med. 2016;4(2) [Crossref]
39- Ghasemzadeh Rahbardar M, Amin B, Mehri S, Mirnajafi-Zadeh S, Hosseinzadeh H. Anti-inflammatory effects of ethanolic extract of Rosmarinus officinalis L. and rosmarinic acid in a rat model of neuropathic pain. Biomedicine & Pharmacotherapy. 2017;86:441 [Crossref]
40- Dong X, An Z, Guo Y, Zhou J, Qin T. Effect of triptolide on expression of oxidative carbonyl protein in renal cortex of rats with diabetic nephropathy. J Huazhong Univ Sci Technol [Med Sci]. 2017;37(1):25 [Crossref]
41- El Kantar S, Yassin A, Nehmeh B, Labaki L, Mitri S, Naser Aldine F, Hirko A, Caballero S, Monck E, Garcia-Maruniak A, Akoury E. Deciphering the therapeutical potentials of rosmarinic acid. Sci Rep. 2022;12(1) [Crossref]
42- Rajabloo Y, Saberi-Karimian M, Soflaei S, Ferns G, Ghayour-Mobarhan M. Syndecans and diabetic complications: A narrative review. The American Journal of the Medical Sciences. 2024;368(2):99 [Crossref]
43- Yaribeygi H, Mohammadi M, Rezaee R, Sahebkar A. Crocin improves renal function by declining Nox‐4, IL‐18, and p53 expression levels in an experimental model of diabetic nephropathy. J of Cellular Biochemistry. 2018;119(7):6080 [Crossref]
44- El Gabbas Z, Bezza K, Laadraoui J, Ait Laaradia M, Kebbou A, Oufquir S, Boukhira A, Aboufatima R, Chait A. Salvia officinalis, Rosmarinic and Caffeic Acids Attenuate Neuropathic Pain and Improve Function Recovery after Sciatic Nerve Chronic Constriction in Mice. Evidence-Based Complementary and Alternative Medicine. 2019;2019:1 [Crossref]
45- Moodi V, Abedi S, Esmaeilpour M, Asbaghi O, Izadi F, Shirinbakhshmasoleh M, Behrouzian M, Shahriari A, Ghaedi E, Miraghajani M. The effect of grapes/grape products on glycemic response: A systematic review and meta‐analysis of randomized controlled trials. Phytotherapy Research. 2021;35(9):5053 [Crossref]
46- Zhu Q, Li X, Chen H, Jin Q. The effects of compound centella formula on OxInflammation and silent information regulator 1 in a high‑fat diet/streptozotocin‑induced diabetic kidney disease rat model. Exp Ther Med. 2021;22(3) [Crossref]
47- An Z, Dong X, Guo Y, Zhou J, Qin T. Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy. J Huazhong Univ Sci Technol [Med Sci]. 2015;35(3):356 [Crossref]
48- Shi Q, Lee D, Féliers D, Abboud H, Bhat M, Gorin Y. Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease. Molecular Metabolism. 2020;36:100968 [Crossref]
49- Kim H, Hwang S, Sung B, Kim Y, Chang Y. Gd-Complex of a Rosmarinic Acid Conjugate as an Anti-Inflammatory Theranostic Agent via Reactive Oxygen Species Scavenging. Antioxidants. 2020;9(8):744 [Crossref]
50- Xiong Y, Zhou L. The Signaling of Cellular Senescence in Diabetic Nephropathy. Oxidative Medicine and Cellular Longevity. 2019;2019:1 [Crossref]
51- Rafieian-Kopaei M, Nasri H. The Ameliorative Effect of Zingiber officinale in Diabetic Nephropathy. Iran Red Crescent Med J. 2014;16(5) [Crossref]
52- An L, Zhou M, Marikar F, Hu X, Miao Q, Li P, Chen J. Salvia miltiorrhizaLipophilic Fraction Attenuates Oxidative Stress in Diabetic Nephropathy through Activation of Nuclear Factor Erythroid 2-Related Factor 2. Am J Chin Med. 2017;45(07):1441 [Crossref]
53- Rafieian-Kopaei M, Nasri H. Comment on: Preventive effect of Teucrium polium on learning and memory deficits in diabetic rats. Med Sci Monit Basic Res. 2013;19:208 [Crossref]
54- Østergaard J, Cooper M, Jandeleit-Dahm K. Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease. J Nephrol. 2020;33(5):917 [Crossref]
55- Wu C, Wang J, Zhang R, Zhao H, Li X, Wang L, Liu P, Li P. Research progress on Cornus officinalis and its active compounds in the treatment of diabetic nephropathy. Front Pharmacol. 2023;14 [Crossref]
56- Gomes I, Porto M, Santos M, Campagnaro B, Pereira T, Meyrelles S, Vasquez E. Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy. Lipids Health Dis. 2014;13(1) [Crossref]
57- Dua T, Joardar S, Chakraborty P, Bhowmick S, Saha A, De Feo V, Dewanjee S. Myricitrin, a Glycosyloxyflavone in Myrica esculenta Bark Ameliorates Diabetic Nephropathy via Improving Glycemic Status, Reducing Oxidative Stress, and Suppressing Inflammation. Molecules. 2021;26(2):258 [Crossref]
58- Ebrahimi Z, Nasli-Esfahani E, Nadjarzade A, Mozaffari-khosravi H. Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial. J Diabetes Metab Disord. 2017;16(1) [Crossref]
59- Лактіонова О, Коляда К, Фоменко Р, Лахно О. ДОДАТКОВІ ПАТОФІЗІОЛОГІЧНІ ШЛЯХИ РОЗВИТКУ ТА ПРОГРЕСУВАННЯ ДІАБЕТИЧНОЇ НЕФРОПАТІЇ. GoS. 2022;(16):518 [Crossref]
60- Nasri H, Rafieian-Kopaei M. Garlic and Kidney Injury Protection. Shiraz E-Med J. 2013;14(4) [Crossref]
61- Ahangarpour A, Oroojan A, Khorsandi L, Shabani R, Mojaddami S. Preventive effects of betulinic acid on streptozotocinnicotinamide induced diabetic nephropathy in male mouse. J Nephropathol. 2016;5(4):128 [Crossref]
62- Bondor C, Potra A, Moldovan D, Rusu C, Ciorba Pop M, Muresan A, Vladutiu D, Kacso I. Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease. Int Urol Nephrol. 2015;47(7):1173 [Crossref]
63- Sherif I. Secoisolariciresinol diglucoside in high-fat diet and streptozotocin-induced diabetic nephropathy in rats: a possible renoprotective effect. J Physiol Biochem. 2014;70(4):961 [Crossref]
64- Asbaghi O, Moodi V, Neisi A, Shirinbakhshmasoleh M, Abedi S, Oskouie F, Eslampour E, Ghaedi E, Miraghajani M. The effect of almond intake on glycemic control: A systematic review and dose–response meta‐analysis of randomized controlled trials. Phytotherapy Research. 2022;36(1):395 [Crossref]
65- Rafieian-Kopaei M. In Vitro Evaluation of Antioxidant Properties of Ten Iranian Medicinal Plants. Iran Red Crescent Med J. 2014;16(6) [Crossref]
66- Ulubay M, Alkan I, Yurt K, Kaplan S. The protective effect of curcumin on the diabetic rat kidney: A stereological, electron microscopic and immunohistochemical study. Acta Histochemica. 2020;122(2):151486 [Crossref]
67- Khan K, Padyana S. Diabetic nephropathy: Ayur‐nutri‐pharmaco approach. Food Safety and Health. 2024;2(3):344 [Crossref]
68- Nasri H. Re Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism. 2013;39(4):375 [Crossref]
69- Suhail D. The Protective Potential of Metformin against Liver Acetaminophen Toxicity. IJRST. 2021;11(3) [Crossref]
70- Rafieian Kopaei M, Baradaran A. Protective Effects of Metformin on Renal Tubular Cells. Iran Red Crescent Med J. 2014;16(9) [Crossref]
71- Alqasim A, Nour Eldin E, Hammadi S, Esheba G. Comparing the renoprotective effects of the antioxidants melatonin, vitamin D and vitamin E in diabetic rats. Journal of Taibah University Medical Sciences. 2020;15(5):351 [Crossref]
72- Shahrani M, Asgari A, Abedi Gheshlaghi Z, Parvin N, Nasri P, Shirzad H, Rafieian Kopaei M. Effect of Kelussia odoratissima Mozaffarian on Lipid and Glucose Profile. Shiraz E-Med J. 2015;16(8) [Crossref]
73- Yaribeygi H, Simental‐Mendía L, Butler A, Sahebkar A. Protective effects of plant‐derived natural products on renal complications. Journal Cellular Physiology. 2019;234(8):12161 [Crossref]
74- Mureșan A, Tomac A, Opriș D, Bandici B, Coșarcă C, Covalcic D, Hălmaciu I, Akácsos-Szász O, Rădulescu F, Lázár K, Stoian A, Tilinca M. Inflammatory Markers Used as Predictors of Subclinical Atherosclerosis in Patients with Diabetic Polyneuropathy. Life. 2023;13(9):1861 [Crossref]
75- Golla U. Emergence of nutraceuticals as the alternative medications for pharmaceuticals. IJCAM. 2018;11(3) [Crossref]
76- Klen J, Dolžan V. SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation. Pharmaceutics. 2023;15(7):1995 [Crossref]
77- Sutariya B, Saraf M. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway. Journal of Ethnopharmacology. 2017;198:432 [Crossref]
78- Dare A, Channa M, Nadar A. L-ergothioneine; a potential adjuvant in the management of diabetic nephropathy. Pharmacological Research - Modern Chinese Medicine. 2022;2:100033 [Crossref]
79- Yonekura Y, Fujii H, Nakai K, Kono K, Goto S, Shinohara M, Nishi S. Anti‐oxidative effect of the β‐blocker carvedilol on diabetic nephropathy in non‐obese type 2 diabetic rats. Clin Exp Pharma Physio. 2015;42(9):972 [Crossref]
80- ALTamimi J, AlFaris N, Alshammari G, Alagal R, Aljabryn D, Aldera H, Alrfaei B, Alkhateeb M, Yahya M. Ellagic acid protects against diabetic nephropathy in rats by regulating the transcription and activity of Nrf2. Journal of Functional Foods. 2021;79:104397 [Crossref]
81- Maqbool M, Dar M, Ara I. Planting a path to kidney health: The vegetarian diet and diabetic nephropathy. 2023;4(1) [Crossref]
82- Deng H, Li Y, Han S, Lan M, Cui L, Alahmadi T, Alharbi S, Li Z. Eriocitrin in the Treatment of Diabetic Nephropathy: Amelioration Against Oxidative Burst and Inflammation Approach. Pharmacognosy Magazine. 2024; [Crossref]
83- Bhuia M, Aktar M, Chowdhury R, Ferdous J, Rahman M, Hasan M, Islam M. Therapeutic potentials of ononin with mechanistic insights: A comprehensive review. Food Bioscience. 2023;56:103302 [Crossref]
84- Veeraswamy S, Raju I, Mohan S. Phytochemical Evaluation and Antioxidant Potential of Polyherbal Extract Mixture—an In Vitro and In Silico Study. Appl Biochem Biotechnol. 2023;195(1):672 [Crossref]
85- Asiwe J, Moke E, Asiwe N, Yovwin G, Nwogueze B, Daubry T. Dryopteris dilatata leaf extract ameliorates streptozotocin-induced diabetic nephropathy in male Wistar rat. Nutrire. 2022;48(1) [Crossref]
86- Soltani-Fard E, Taghvimi S, Karimi F, Vahedi F, Khatami S, Behrooj H, Deylami Hayati M, Movahedpour A, Ghasemi H. Urinary biomarkers in diabetic nephropathy. Clinica Chimica Acta. 2024;561:119762 [Crossref]
87- Baradaran A. Commentary on: effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial. DARU J Pharm Sci. 2013;21(1) [Crossref]
88- Albeladi F, Mostafa M, Zayed M, Atta H. Association of Polymorphisms in Antioxidant Enzyme-Encoding Genes with Diabetic Nephropathy in a Group of Saudi Arabian Patients with Type II Diabetes Mellitus. IJGM. 2022;Volume 15:5919 [Crossref]
89- Zhou D, Zhou T, Tang S, Li Q, Li W, Gan G, Li M, Chen Q. Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy. Front Endocrinol. 2024;15 [Crossref]